This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Jean Theresa Jacob: Innovator in Ocular Drug Delivery Devices
Introduction
Jean Theresa Jacob is a notable inventor based in the United States. He has made significant contributions to the field of ocular drug delivery, focusing on innovative methods to enhance the treatment of eye disorders. His work emphasizes the importance of effective drug delivery systems in improving patient outcomes.
Latest Patents
Jean Theresa Jacob holds 0 patents. However, he has developed a method for creating ocular drug delivery devices. This method involves exposing a solid, shaped cellulose polymer to a solution containing an active pharmaceutical ingredient (API) and a solvent that can solubilize the API. The polymer absorbs a portion of the solution, which includes both the API and solvent. The process may also involve removing some of the absorbed solvent by allowing it to evaporate or by drying the polymer. Various cellulose polymers, such as hydroxypropyl cellulose, can be utilized, and a range of APIs, including Cyclosporine, Tobramycin, and Vancomycin, can be incorporated. The ocular delivery devices produced through these methods are designed to treat a variety of eye disorders.
Career Highlights
Throughout his career, Jean Theresa Jacob has worked with reputable organizations, including Aton Pharma, Inc. and Louisiana State University and Agricultural & Mechanical College. His experience in these institutions has allowed him to collaborate with other professionals in the field and contribute to advancements in ocular drug delivery technologies.
Collaborations
Some of Jean Theresa Jacob's notable coworkers include Kevin Halloran and Yuri Mckee. Their collaborative efforts have likely played a role in the development of innovative solutions in ocular drug delivery.
Conclusion
Jean Theresa Jacob's work in ocular drug delivery devices showcases his commitment to improving healthcare through innovation. His methods and collaborations highlight the potential for advancements in treating eye disorders, making a significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile